期刊文献+

盆腔孤立性淋巴结转移对宫颈癌患者预后影响及相关影响因素 被引量:5

原文传递
导出
摘要 目的:探讨盆腔孤立性淋巴结转移对宫颈癌患者预后影响,并寻找影响盆腔孤立性淋巴结转移的相关因素。方法:选择宫颈浸润癌患者153例,其中有1枚淋巴结转移者为孤立转移组,无淋巴结转移为无转移组。对比两组患者年龄、临床分期、肿瘤大小、病理类型、分化程度、浸润深度、脉管浸润、宫旁浸润、宫体转移等情况。结果:153例患者中142例接受4~92个月的随访,孤立转移组患者5年生存率为53.1%(17/32),无转移组为83.6%(92/110),差异有统计学意义(P<0.05)。单因素分析中,临床分期、浸润深度、脉管浸润、宫旁浸润为孤立淋巴结转移的相关因素(P<0.05)。Logistic回归分析中显示,临床分期、浸润深度、脉管浸润为影响宫颈癌孤立淋巴结转移的独立危险因素(P<0.05)。结论:宫颈癌患者发生孤立淋巴结转移时预后相对较差,临床分期较晚、宫颈浸润深度≥1/2肌层及有脉管浸润的宫颈癌患者易发孤立淋巴结转移。
出处 《中国妇幼保健》 CAS 北大核心 2012年第26期4056-4057,共2页 Maternal and Child Health Care of China
  • 相关文献

参考文献7

二级参考文献26

  • 1Curtin J P,Hoskins W J,Venkatraman E S,et al.Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy(RH-PLND):a randomized phase Ⅲ trial[J].Gynecol Oncol,1996,61(1):3-10.
  • 2Aoki Y,Sasaki M,Watanabe M,et al.High-risk group in node-positive patients with stage ⅠB,ⅡA,and ⅡB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation[J].Gynecol Oncol,2000,77(2):305-309.
  • 3Sankaranarayanan R.Overview of cervical cancer in the developing world.FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer[J].Int J Gynaecol Obstet,2006,95(Suppl 1):S205-S210.
  • 4Rutledge T L,Kamelle S A,Tillmanns T D,et al.A comparison of stages ⅠB1 and ⅠB2 cervical cancers treated with radical hysterectomy.Is size the real difference?[J].Gynecol Oncol,2004,95(1):70-76.
  • 5Milam M R,Frumovitz M,dos Reis R,et al.Preoperative lymph-vascular space invasion is associated with nodal metastases in women with early-stage cervical cancer[J].Gynecol Oncol,2007,106(1):12-15.
  • 6Narayan K,McKenzie A F,Hicks R J,et al.Relation between FIGO stage,primary tumor volume,and presence of lymph node metastases in cervical cancer patients referred for radiotherapy[J].Int J Gynecol Cancer,2003,13(5):657-663.
  • 7Yeasmin S,Nakayama K,Ishikawa M,et al.A case of bilateral pelvic lymph node involvement in stage 1a1 squamous cell carcinoma of cervix and a review of the literature[J].Int J Clin Oncol,2009,14(6):564-567.
  • 8Takeda N,Sakuragi N,Takeda M,et al.Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy[J].Acta Obstet Gynecol Scand,2002,81(12):1144-1151.
  • 9Kim W Y,Chang S J,Chang K H,et al.Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy warrants trial treatment modification[J].J Gynecol Oncol,2009,20(1):17-21.
  • 10Park J Y,Kim D Y,Kim J H,et al.Further stratification of risk groups in patients with lymph node metastasis after radical hysterectomy for early-stage cervical cancer[J].Gynecol Oncol,2010,117(1):53-58.

共引文献105

同被引文献63

  • 1林开武,张碧清,薛晓玲.宫颈癌的MRI分期与临床及病理分期对照研究[J].医学影像学杂志,2010,20(12):1853-1855. 被引量:35
  • 2景钊,龚玲,董磊,邹长林,李文峰.年轻宫颈癌盆腔淋巴结转移预测的多因素分析[J].江西医药,2006,41(8):588-590. 被引量:6
  • 3孙建衡,蔡树模,高永良.妇科肿瘤学[M].北京:北京大学医学出版社,2011:2-10.
  • 4Zubillaga-Guerrero MI, Illades-Aguiar B, Leyva-Vazquez MA, etal. The integration of HR-HPV increases the expression of cyc-lins A and E in cytologies with and without low-grade lesions[J].J Cytol,2013,30(1) :l-7.
  • 5Dobson SR,McNeil S, Dionne M, et al. Immunogenicity of 2doses of HPV vaccine in younger adolescents vs 3 doses inyoung women: a randomized clinical trial[J]. JAMA, 2013,309(17):1793-1802.
  • 6Bragelmann J,Dagogo-Jack I,El Dinali M,et al. Oral cavitytumors in younger patients show a poor prognosis and do notcontain viral RNA[J]. Oral Oncol,2013,49(6) :525-533.
  • 7Jabtonowska D, Marszatek A,Bodnar M. Tabacco smoking,HPV infection and changes in cervix[J]. Przegl Lek,2012,69(10):740-743.
  • 8Hacker NF, Barlow EL, Scurry J, et al. Primary surgical manage- ment with tailored adjuvant radiation for stage IB2 cervical cancer [ J]. Obstet Gynecol,2013,121 (4) :765-772.
  • 9Lee TS, Kang SB, Kim YT, et al. Chemoradiation with paclitaxel and carboplatin in high-risk cervical cancer patients after radical hysterectomy: a Korean Gynecologic Oncology Group study [ J ]. Radiat Oncol Biol Phys,2013,86(2) :304-310.
  • 10Okazawa M, Mabuchi S, Isohashi F, et M. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience[J]. Int J Gynecol Canc- er, 2013, 23(3) :567-575.

引证文献5

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部